Go to article
Posted by CoV Report on September 29, 2021 11:18 amTags: Categories: US National Stories
The study was conducted when third-dose eligibility was limited to patients with moderate to severe immunocompromising conditions.
< The Coronavirus Report home
Everything you need to know to stay updated on the Coronavirus